Brief: Kronos Bio Reports Q3 Net Loss Of $0.57 Per Share
08/11/2022 22:46
Nov 8 (Reuters) - Kronos Bio Inc KRON.O :
* KRONOS BIO REPORTS RECENT BUSINESS PROGRESS AND
THIRD-QUARTER
2022 FINANCIAL RESULTS
* KRONOS BIO INC - $270.3 MILLION IN CASH, CASH EQUIVALENTS
AND
INVESTMENTS AS OF SEPT. 30, 2022, WITH EXPECTED CASH RUNWAY INTO
Q2 2025
* KRONOS BIO INC - NET LOSS FOR Q3 OF 2022 WAS $32.3
MILLION, OR
$0.57 PER SHARE
Source text for Eikon: ID:nGNX9NzcB9
Further company coverage: KRON.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kronos Bio
See all newsBrief: Kronos Bio Inc - Terminates Office Lease At 301 Binney Street - SEC Filing
Brief: Kronos Bio Inc - Enters Transition Agreement With Genentech
U.S. STOCKS ON THE MOVE - Ambarella, Dell, Nordstrom
U.S. STOCKS ON THE MOVE - Golden Ocean, Guess, Symbotic
U.S. STOCKS ON THE MOVE-HP, Urban Outfitters, 3D Systems